Pharma CEO Shkreli Says He Was Targeted
Because he raised price of life-saving AIDS drug.

Lucas Jackson/Reuters
Embattled pharmaceutical executive Martin Shkreli, who was arrested last week on charges of securities fraud, said Sunday he was unfairly targeted because he raised the price of life-saving drugs. In his first interview since his arrest, the 32-year-old told The Wall Street Journal that authorities were coming after him for his much-criticized move to raise the price of the AIDS-related drug Daraprim by 5,000 percent. “Beating the person up and then trying to find the merits to make up for it—I would have hoped the government wouldn’t take that kind of approach,” he said. Shkreli stepped down as CEO of Turing Pharmaceuticals last week, just one day after he was arrested on charges of securities fraud and misleading investors in his previous hedge fund. The ex-CEO also said Sunday his phone, social media, and email accounts were hacked. Shkreli’s Twitter account on Sunday included posts that read, “I am now a god.”
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.